Concepedia

Chia‐Chi Lin

CL

25

Publications

844

Citations

15

H-Index

2007

Active since

Affiliations

National Taiwan University Hospital(Current)

Novartis (Switzerland)

The University of Texas MD Anderson Cancer Center

Seoul National University Hospital

National Taiwan University

Chia‐Chi Lin is an author at National Taiwan University Hospital specializing in medicine, radiation oncology, and oncology.

Top concepts

Publications per year

2007–2024

25

Publications

25

Phase I Study of Dovitinib (TKI258), an Oral FGFR, VEGFR, and PDGFR Inhibitor, in Advanced or Metastatic Renal Cell Carcinoma

Eric Angevin, José A. López-Martín, Chia‐Chi Lin et al. · Clinical Cancer Research · 2013 · 129 citations

Zinc oxide nanoparticles alter hatching and larval locomotor activity in zebrafish (Danio rerio)

Te-Hao Chen, Chia‐Chi Lin, Pei‐Jie Meng · Journal of Hazardous Materials · 2013 · 116 citations

, , +8

Phase II Results of Dovitinib (TKI258) in Patients with Metastatic Renal Cell Cancer

Bernard Escudier, Viktor Grünwald, Alain Ravaud et al. · Clinical Cancer Research · 2014 · 56 citations · Full text

Pembrolizumab in Asia‐Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from <scp>KEYNOTE</scp>‐012

Makoto Tahara, Kei Muro, Yasuhisa Hasegawa et al. · Cancer Science · 2017 · 52 citations · Full text

, , +13

Exposure‐Response Relationships in Patients With HER2‐Positive Metastatic Breast Cancer and Other Solid Tumors Treated With Trastuzumab Deruxtecan

Ophelia Yin, Hiroji Iwata, Chia‐Chi Lin et al. · Clinical Pharmacology & Therapeutics · 2021 · 47 citations · Full text

Rows per page

1–5 of 25